LeMaitre Vascular Crushes Q1 Targets, Raises Full-Year Guidance Amid Strong Momentum
LeMaitre Vascular reports 11% organic Q1 growth, expanding margins, and raises 2026 guidance on strong Artegraft performance and geographic expansion.
LMATvascular devicesrevenue growth












